Since its discovery, CHD1L has been further identified as a key biomarker and oncogenic protein in many cancers, including colorectal, breast, bladder, lung, and kidney cancers, indicating its crucial role in cancer progression [2, 6–8]. This evidence concerns the gene CHD1L and cancer.